Christie Gooden, MD
Transplant Surgery · Dallas, TXNPI 1679788947
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.6%), education and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 48.8% of the total. Reporting peaked in 2021 at $4,075 and has fallen 91.2% since, to $358 in 2025.
Across 49 payments — averaging $170.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$4K
- Intuitive Surgical$3K
- Sanofi-aventis U.S. LLC$284
- Intercept Pharmaceuticals, Inc.$254
- Takeda Pharmaceuticals U.S.A., Inc.$145
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$92
- plus $468 from 14 others
What the payments were for
- Consulting fees$4,05049%
- Travel & lodging$5226%
- Food & beverage$1,26015%
- Education$2,50030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 3 | $4,067 |
| Intuitive Surgical | 4 | $3,022 |
| Sanofi-aventis U.S. LLC | 3 | $284 |
| Intercept Pharmaceuticals, Inc. | 12 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $145 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $92 |
| Madrigal Pharmaceuticals | 3 | $79 |
| Medtronic | 1 | $71 |
| Laborie Medical Technologies Corp. | 1 | $38 |
| Merck | 1 | $31 |
| Lemaitre Vascular, Inc. | 1 | $29 |
| Eisai Inc. | 1 | $28 |
| AbbVie | 1 | $28 |
| AstraZeneca | 1 | $28 |
| Johnson & Johnson | 1 | $27 |
| Getinge USA Sales, LLC | 1 | $25 |
| Covidien LP | 2 | $25 |
| Sequana Medical US Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Eton Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$2,500
- Da Vinci Surgical System$510
- THYMOGLOBULIN$140
How this compares
$8,333 in reported general payments places this provider in the 75th percentile of 70 transplant surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Dallas
- Goran KlintmalmDallas$88K
- Alejandro MejiaDallas$20K
- Richard RuizDallas$16K
- Steven HanishDallas$7K
- Lori KautzmanDallas$7K
- Jason SchwartzDallas$5K
- Tiffany AnthonyDallas$5K
- Anji WallDallas$4K
- Gregory McKennaDallas$4K
- Seung Hee LeeDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.